Back
COPT Defense Properties Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
28
CDP
COPT Defense Properties
Last Price:
$26.92
Seasonality Move:
2.3%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$99.80
Seasonality Move:
6.73%
Sell
28
COPT Defense Properties (CDP)
is a Sell
Is COPT Defense Properties a Buy, Sell or Hold?
-
The current COPT Defense Properties [CDP] share price is $26.75. The Score for CDP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CDP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CDP Stock Price Chart
What is COPT Defense Properties's stock price today?
-
The COPT Defense Properties share price today is $26.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CDP is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $100.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CDP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 36.9 | Sell |
Chaikin Money Flow: | -490743 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.68 - 28.82) | Sell |
Bollinger Bands (100): | (28.5 - 32.36) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.22 | Sell |
Relative Strength Index (14 RSI): | 38.38 | Sell |
Chaikin Money Flow: | 544784 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.87 - 112.63) | Sell |
Bollinger Bands (100): | (110.05 - 127.23) | Sell |
CDP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.89 | Sell |
20-day SMA: | 27.35 | Sell |
50-day SMA: | 28.93 | Sell |
200-day SMA: | 28.96 | Sell |
8-day EMA: | 26.93 | Sell |
20-day EMA: | 27.43 | Sell |
50-day EMA: | 28.63 | Sell |
200-day EMA: | 28.76 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.91 | Sell |
20-day SMA: | 106.68 | Sell |
50-day SMA: | 114.29 | Sell |
200-day SMA: | 126.68 | Sell |
8-day EMA: | 104.06 | Sell |
20-day EMA: | 106.89 | Sell |
50-day EMA: | 112.29 | Sell |
200-day EMA: | 121 | Sell |
COPT Defense Properties Earnings Growth & CDP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.03 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
COPT Defense Properties Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |